|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Available-for-sale securities | ||||||||||||
| Accounts receivable, net | ||||||||||||
| Inventories | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Acquired product rights, net | ||||||||||||
| Other assets (includes restricted cash of $3,759 at June 30, 2014 and $4,531 at December 31, 2013) | ||||||||||||
| Total assets | ||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued compensation and benefits | ||||||||||||
| Other accrued liabilities | ||||||||||||
| Convertible notes - current | ||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||
| Total current liabilities | ||||||||||||
| Deferred rent | ||||||||||||
| Convertible notes - noncurrent | ||||||||||||
| Embedded conversion derivative | ||||||||||||
| Other long-term liabilities | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Common stock, $0.001 par value; 175,000 shares authorized; 102,918 and 89,608 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive income | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' equity | ||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
